RoundTable Selling Bioniche Pharma for $550 Million
RoundTable Healthcare Partners has agreed to sell Bioniche Pharma Holdings Ltd., an Ireland-based injectable drugmaker, to Mylan Inc. (Nasdaq: MYL) The deal is valued at $550 million in cash.
14 July 2010•2 mins read
